Evidence map›Paper›PMID 39501581›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Catalytically Active Ti-Based Nanomaterials for Hydroxyl Radical Mediated Clinical X-Ray Enhancement.

Lukas R H Gerken, Claire Beckers, Beatrice A Brugger, Vera M Kissling, Alexander Gogos, Shianlin Wee, Maria R Lukatskaya, Hans Schiefer, Ludwig Plasswilm, Martin Pruschy and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lukas R H GerkenNanoparticle Systems Engineering Laboratory, Institute of Energy and Process Engineering (IEPE), Department of Mechanical and Process Engineering (D-MAVT), ETH Zurich, Sonneggstrasse 3, Zurich, 8092, Switzerland.ORCID 0000-0002-8568-2674
Claire BeckersLaboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Winterthurerstrasse 190, Zurich, 8057, Switzerland.ORCID 0000-0003-4678-6865
Beatrice A BruggerParticles-Biology Interactions Laboratory, Department of Materials Meet Life, Swiss Federal Laboratories for Materials Science and Technology (Empa), Lerchenfeldstrasse 5, St. Gallen, 9014, Switzerland.ORCID 0000-0002-2947-9583
Vera M KisslingParticles-Biology Interactions Laboratory, Department of Materials Meet Life, Swiss Federal Laboratories for Materials Science and Technology (Empa), Lerchenfeldstrasse 5, St. Gallen, 9014, Switzerland.ORCID 0000-0002-4524-9905
Alexander GogosNanoparticle Systems Engineering Laboratory, Institute of Energy and Process Engineering (IEPE), Department of Mechanical and Process Engineering (D-MAVT), ETH Zurich, Sonneggstrasse 3, Zurich, 8092, Switzerland.ORCID 0000-0001-6233-512X
Shianlin WeeElectrochemical Energy Systems Laboratory, Institute of Energy and Process Engineering (IEPE), Department of Mechanical and Process Engineering (D-MAVT), ETH Zurich, Sonneggstrasse 3, Zurich, 8092, Switzerland.ORCID 0000-0002-8791-6905
Maria R LukatskayaElectrochemical Energy Systems Laboratory, Institute of Energy and Process Engineering (IEPE), Department of Mechanical and Process Engineering (D-MAVT), ETH Zurich, Sonneggstrasse 3, Zurich, 8092, Switzerland.ORCID 0000-0002-2794-4322
Hans SchieferDepartment of Radiation Oncology, Cantonal Hospital St. Gallen (KSSG), Rorschacherstrasse 95, St. Gallen, CH-9007, Switzerland.
Ludwig PlasswilmDepartment of Radiation Oncology, Cantonal Hospital St. Gallen (KSSG), Rorschacherstrasse 95, St. Gallen, CH-9007, Switzerland.
Martin PruschyLaboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Winterthurerstrasse 190, Zurich, 8057, Switzerland.ORCID 0000-0002-3124-9015
Inge K HerrmannNanoparticle Systems Engineering Laboratory, Institute of Energy and Process Engineering (IEPE), Department of Mechanical and Process Engineering (D-MAVT), ETH Zurich, Sonneggstrasse 3, Zurich, 8092, Switzerland.ORCID 0000-0002-3018-6796

Funding

Eidgenössische Technische Hochschule Zürich ETH-07 21-2Krebsliga Schweiz KFS-4868-08-2019Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 181290
6 · The paper itself

Abstract

Nanoparticle radioenhancement offers a promising strategy for augmenting radiotherapy by locally increasing radiation damage to tumor tissue. While past research has predominantly focused on nanomaterials with high atomic numbers, such as Au and HfO

Indexed as

Hydroxyl RadicalNanostructuresTitaniumCatalysisCell Line, TumorHumansX-RaysHydroxyl RadicalTitaniumtitanium dioxidephotocatalystradiosensitizationradiotherapyreactive oxygen speciestitanium

Identifiers

PMID39501581
PMCPMC11653640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.